Faraday Pharmaceuticals
- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- faradaypharma.com
- Total Funding
- $99.2M
- Last Round
- $52.8M Series BNov 2022
About
Faraday Pharmaceuticals is a clinical-stage biopharmaceutical company founded by Dr. Mark Roth of the Fred Hutchinson Cancer Center. The company pioneered the use of elemental reducing agents to protect against muscle loss in cardiac and critical care settings. As of 2025, the company has ceased operations and is winding down.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account